Schemes such as Astra Zeneca and Reckitt Benckiser have made sizable changes to their life expectancy assumptions, but Owen Walker discovers small, frequent reviews are better to avoid the risk of poor data.
If you are already a registered you can SIGN IN now
It’s quick and easy, and as a registered user you’ll have full access to all Pension Expert articles. You will also be able to recieve editorial emails.